# Arrow Financial Corp: Form 10-Q for the period ended Jun 30, 2026

- Company: [Arrow Financial Corp](/companies/arow.md) (CIK 717538)
- Form: 10-Q
- Filed: 2026-08-06
- Accepted by EDGAR: Aug 6, 2026, 13:50 ET
- Period: 2026-06-30
- Accession: 0000717538-26-000117
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/717538/000071753826000117/arow-20260630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/717538/000071753826000117/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2026-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Interest expense | 3 months, 2026-04-01 to 2026-06-30 | $17.7m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2026-01-01 to 2026-06-30 | $35.4m | us-gaap:InterestExpense |
| Income tax | 3 months, 2026-04-01 to 2026-06-30 | $2.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2026-01-01 to 2026-06-30 | $6.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2026-04-01 to 2026-06-30 | $11.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2026-01-01 to 2026-06-30 | $24.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2026-04-01 to 2026-06-30 | $0.66 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2026-01-01 to 2026-06-30 | $1.48 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2026-04-01 to 2026-06-30 | $0.66 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2026-01-01 to 2026-06-30 | $1.48 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2026-04-01 to 2026-06-30 | 16,467,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2026-01-01 to 2026-06-30 | 16,438,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2026-01-01 to 2026-06-30 | $31.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2026-01-01 to 2026-06-30 | $5.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months, 2026-01-01 to 2026-06-30 | $483.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Total assets | at 2026-06-30 | $4.48bn | us-gaap:Assets |
| Total liabilities | at 2026-06-30 | $4.04bn | us-gaap:Liabilities |
| Short-term borrowings | at 2026-06-30 | $310.2m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2026-06-30 | $446.3m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 1,484 characters.

### Unregistered Sales of Equity Securities and Use of Proceeds

#### Unregistered Sales of Equity Securities

None.

#### Issuer Purchases of Equity Securities

The following table presents information about repurchases by Arrow during the three months ended June 30, 2026 of Arrow's common stock (the only class of equity securities registered pursuant to Section 12 of the Securities Exchange Act of 1934).

No shares were repurchased during the six month period ended June 30, 2026 under the Company's current repurchase authorization and as of June 30, 2026, $5,066,228 remained available. The repurchase authorization has no expiration date.

| Second Quarter 2026 Calendar Month | (A) Total Number of Shares Purchased 1 | (B) Average Price Paid Per Share 1 | (C) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs2 | (D) Maximum Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs 2 |
| --- | ---: | ---: | ---: | ---: |
| April 1-30 | — | $— | — | $5,066,228 |
| May 1-31 | — | — | — | 5,066,228 |
| June 1-30 | — | — | — | 5,066,228 |
| Total | — | — | — |  |

1 No shares were purchased in the open market under the ESOP on behalf of the participants under the ESOP by the

administrator of the ESOP or by Arrow pursuant to the Company's most recent authorization for the repurchase of shares.

2 No shares were acquired under the most recent authorization for the repurchase of shares in April, May or June 2026.

## Market risk

As filed, 2,641 characters.

### Defaults Upon Senior Securities - None

### Mine Safety Disclosures - None

### Other Information

### Rule 10b5-1 Trading Arrangements

During the three months ended June 30, 2026, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

### Exhibits

| Exhibit Number | Exhibit |
| --- | --- |
| 3.(i) | Certificate of Incorporation of the Registrant as Amended through June 3, 2019, incorporated by reference from the Registrant's Current Report on Form 8-K filed June 5, 2019, Exhibit 3.1 |
| 3.(ii) | By-laws of the Registrant, as amended, incorporated herein by reference from the Registrant’s Current Report on Form 8-K filed on February 1, 2024, Exhibit 3.1 |

The following exhibits are submitted herewith:

| Exhibit Number | Exhibit |
| --- | --- |
| 10.1 \* | Employment Agreement, dated July 1, 2026, between the Company and Rocco F. Arcuri, Sr. |
| 10.2 \* | Settlement and Non-Competition Agreement between Adirondack Bank and Rocco F. Arcuri, Sr. |
| 10.3 \* | Supplemental Executive Retirement Plan Agreement between Adirondack Bank and Rocco F. Arcuri, Sr. |
| 31.1 | Certification of Chief Executive Officer under SEC Rule 13a-14(a)/15d-14(a) |
| 31.2 | Certification of Chief Financial Officer under SEC Rule 13a-14(a)/15d-14(a) |
| 32 | Certification of Chief Executive Officer under 18 U.S.C. Section 1350 and Certification of Chief Financial Officer under 18 U.S.C. Section 1350 |
| 101.INS | XBRL Instance Document |
| 101.SCH | XBRL Taxonomy Extension Schema Document |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | XBRL Taxonomy Extension Labels Linkbase Document |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
| \* Management contracts or compensation plans required to be filed as an exhibit. |  |

66

### SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

### ARROW FINANCIAL CORPORATION

Registrant

|  |  |
| --- | --- |
| August 6, 2026 | /s/ David S. DeMarco |
| Date | David S. DeMarco |
|  | President and Chief Executive Officer |
|  | (Principal Executive Officer) |
| August 6, 2026 | /s/ Penko Ivanov |
| Date | Penko Ivanov |
|  | Chief Financial Officer |
|  | (Principal Financial and Accounting Officer) |

67

Filed Aug 6, 2026.
Source: SEC EDGAR, the filing index for accession 0000717538-26-000117. Last ingested by Listed: Oct 29, 2026, 08:06 ET. No prices; not investment advice.
